Your browser doesn't support javascript.
loading
Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer.
Pennock, Michael; Halmos, Balazs; Bodner, William; Cheng, Haiying; Gucalp, Rasim; Ohri, Nitin.
Affiliation
  • Pennock M; Albert Einstein College of Medicine and Montefiore Medical Center, Department of Radiation Oncology, 1625 Poplar Street, Suite 101, Bronx, NY 10461, United States.
  • Halmos B; Albert Einstein College of Medicine and Montefiore Medical Center, Department of Oncology, 1695 Eastchester Road, Bronx, NY 10461-2374, United States.
  • Bodner W; Albert Einstein College of Medicine and Montefiore Medical Center, Department of Radiation Oncology, 1625 Poplar Street, Suite 101, Bronx, NY 10461, United States.
  • Cheng H; Albert Einstein College of Medicine and Montefiore Medical Center, Department of Oncology, 1695 Eastchester Road, Bronx, NY 10461-2374, United States.
  • Gucalp R; Albert Einstein College of Medicine and Montefiore Medical Center, Department of Oncology, 1695 Eastchester Road, Bronx, NY 10461-2374, United States.
  • Ohri N; Albert Einstein College of Medicine and Montefiore Medical Center, Department of Radiation Oncology, 1625 Poplar Street, Suite 101, Bronx, NY 10461, United States.
Clin Transl Radiat Oncol ; 41: 100643, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37346274

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Transl Radiat Oncol Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Transl Radiat Oncol Year: 2023 Document type: Article Affiliation country: Country of publication: